Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125177362 | 12517736 | 2 | F | 20021016 | 20160728 | 20160630 | 20160805 | EXP | PHHY2016GB085771 | SANDOZ | 25.00 | YR | F | Y | 0.00000 | 20160806 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125177362 | 12517736 | 1 | PS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, QD | 5079.16699 | MG | U | U | 75566 | 20 | MG | QD | |||
| 125177362 | 12517736 | 2 | SS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Oral | UNK | 5079.16699 | MG | U | U | 75566 | ||||||
| 125177362 | 12517736 | 3 | SS | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125177362 | 12517736 | 1 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125177362 | 12517736 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125177362 | 12517736 | Agitation | |
| 125177362 | 12517736 | Anxiety | |
| 125177362 | 12517736 | Confusional state | |
| 125177362 | 12517736 | Diplopia | |
| 125177362 | 12517736 | Disturbance in attention | |
| 125177362 | 12517736 | Dizziness | |
| 125177362 | 12517736 | Drug withdrawal syndrome | |
| 125177362 | 12517736 | Emotional poverty | |
| 125177362 | 12517736 | Eyelid ptosis | |
| 125177362 | 12517736 | Fatigue | |
| 125177362 | 12517736 | Hallucination | |
| 125177362 | 12517736 | Hallucination, auditory | |
| 125177362 | 12517736 | Hallucination, visual | |
| 125177362 | 12517736 | Headache | |
| 125177362 | 12517736 | Hyperhidrosis | |
| 125177362 | 12517736 | Influenza like illness | |
| 125177362 | 12517736 | Insomnia | |
| 125177362 | 12517736 | Lethargy | |
| 125177362 | 12517736 | Memory impairment | |
| 125177362 | 12517736 | Nausea | |
| 125177362 | 12517736 | Nightmare | |
| 125177362 | 12517736 | Panic attack | |
| 125177362 | 12517736 | Paraesthesia | |
| 125177362 | 12517736 | Self-injurious ideation | |
| 125177362 | 12517736 | Suicidal ideation | |
| 125177362 | 12517736 | Tremor | |
| 125177362 | 12517736 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125177362 | 12517736 | 1 | 20020204 | 0 | ||
| 125177362 | 12517736 | 2 | 20030422 | 20030828 | 0 |